Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Filings indexed 1,398 across all filing types
Latest filing 2015-10-08 Investor Presentation
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Goldman Sachs EMEA Leveraged Finance Conference:
Investor Presentation Classification · 98% confidence The document is structured as a presentation, indicated by the title 'Goldman Sachs - EMEA Leveraged Finance Conference October 8, 2015 - London' and the 'Agenda' section. It contains detailed financial figures, segment breakdowns (Fresenius Medical Care, Kabi, Helios, Vamed), growth rates, and operational statistics, typical of an investor briefing or presentation given at a conference. This format strongly aligns with an Investor Presentation (IP), which is a detailed presentation for investors focusing on financials, strategy, and market position. It is not a formal regulatory filing like a 10-K or an Earnings Release (ER), but rather a presentation used to communicate performance and strategy to the investment community.
2015-10-08 English
Roadshow Kopenhagen
Investor Presentation Classification · 98% confidence The document is titled 'Roadshow Copenhagen October 6, 2015' and contains extensive slides detailing the company's business segments (Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed), financial results for Q2/H1 2015, outlook updates, and guidance revisions. This structure, focusing on presenting strategy, performance metrics, and future targets to investors during a specific event (Roadshow), strongly indicates an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K or an Earnings Release (ER) which typically focuses only on the official results announcement. Since it is a presentation deck used for investor communication, 'IP' is the most appropriate classification.
2015-10-06 English
Roadshow Stockholm
Investor Presentation Classification · 98% confidence The document text is titled 'Roadshow Stockholm October 5, 2015' and contains extensive slides detailing the company's business segments (Fresenius Medical Care, Kabi, Helios, Vamed), financial results for Q2/H1 2015, updated outlooks, and historical performance comparisons. This structure—a presentation format with segment breakdowns, financial tables, and forward-looking guidance updates—is characteristic of an Investor Presentation (IP) used during roadshows or investor days, rather than a formal regulatory filing like a 10-K or a brief Earnings Release (ER). The content is too detailed for an ER but is clearly a presentation deck, not a full annual report or a simple announcement of a report.
2015-10-05 English
Credit Suisse Global Credit Products Conference
Investor Presentation Classification · 98% confidence The document text is clearly structured as a presentation, indicated by the title '# Health Care Worldwide', the date 'October 1, 2015', the mention of a specific conference ('Crédit Suisse – Global Credit Products Conference'), and the presence of an 'Agenda' and 'Safe Harbor Statement'. It contains detailed financial figures, segment breakdowns, and growth metrics typical of an investor briefing. This format strongly suggests an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K or an Earnings Release (ER), which are typically text-heavy reports or press releases, nor is it a short announcement (RPA/RNS).
2015-10-01 English
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Total Voting Rights Announcement' and explicitly states the total number of voting rights as of September 30, 2015, referencing Article 26a of the WpHG (German Securities Trading Act). This type of announcement, detailing the total number of shares carrying voting rights, directly relates to shareholder voting structure and rights. Among the provided definitions, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is the most appropriate fit, as it covers announcements related to voting rights, even if it's not the final result of a specific vote, but rather the total base for voting rights.
2015-09-30 English
Roadshow Lugano
Investor Presentation Classification · 98% confidence The document is titled 'Roadshow Lugano September 30, 2015' and contains slides presenting detailed financial results (Sales, EBIT, Net Income) for Q2/H1 2015, segment performance updates, and revised outlooks for the group and its divisions (Fresenius Medical Care, Kabi, Helios, Vamed). It includes historical performance data, forward-looking statements, and detailed financial tables. This structure is characteristic of an Investor Presentation (IP) used during roadshows or investor days to communicate strategy and performance updates to the investment community. It is not a formal regulatory filing like a 10-K or an Earnings Release (ER), which typically only provides the initial summary announcement. The presence of 'Attachments' with P&L statements suggests it is a comprehensive presentation document.
2015-09-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.